Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
CAR T Cells After Lymphodepletion for the Treatment of IL13Rα2 Positive Recurrent or Refractory Brain Tumors in Children
Apply
Chemotherapy & Cellular Immunotherapy
CAR T Cells After Lymphodepletion for the Treatment of IL13Rα2 Positive Recurrent or Refractory Brain Tumors in Children
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step